The epidermal growth factor receptor, EGFR, is a transmembrane receptor tyrosine kinase (RTK), known to be overexpressed in approximately 90% of tumors [1] that strongly affects the quality of life and outcomes of cancer patients all over the world [2]. Here, EGFR is linked to cancer.